Series B funding round for ReCode Therapeutics raising $80M in October 2021
Series B funding round for ReCode Therapeutics raising $80M in October 2021
| Investor | Firm Type | Partner |
|---|
EcoR1 CapitalLEAD | Hedge Fund | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Corporate Venture Capital | — | |
| Angel | Sam Altman |
This company has completed 7 funding rounds. Current round is highlighted.
Total Raised
$584M
Top Valuation
-
ReCode Therapeutics raised $80M in a Series B round.
The round was announced on 10/01/21.
The round was led by Oleg Nodelman.